Does BAMLANIVIMAB Cause Intentional product use issue? 66 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Intentional product use issue have been filed in association with BAMLANIVIMAB. This represents 1.3% of all adverse event reports for BAMLANIVIMAB.
66
Reports of Intentional product use issue with BAMLANIVIMAB
1.3%
of all BAMLANIVIMAB reports
3
Deaths
24
Hospitalizations
How Dangerous Is Intentional product use issue From BAMLANIVIMAB?
Of the 66 reports, 3 (4.5%) resulted in death, 24 (36.4%) required hospitalization, and 1 (1.5%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BAMLANIVIMAB. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does BAMLANIVIMAB Cause?
Dyspnoea (833)
Infusion related reaction (663)
Pyrexia (641)
Chills (453)
Oxygen saturation decreased (448)
Nausea (422)
Covid-19 (346)
Cough (342)
Covid-19 pneumonia (313)
Hypoxia (310)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which BAMLANIVIMAB Alternatives Have Lower Intentional product use issue Risk?
BAMLANIVIMAB vs BAMLANIVIMAB\ETESEVIMAB
BAMLANIVIMAB vs BARACLUDE
BAMLANIVIMAB vs BARICITINIB
BAMLANIVIMAB vs BARIUM
BAMLANIVIMAB vs BARNIDIPINE